Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11253671 | 0.98 | MCL1 (0.96) | MCL1GAAKMT2AMEN1ALDH1A1 | |
| SCHEMBL2263308 | 0.90 | MCL1 (0.81) | MCL1GAAKMT2AMEN1ALDH1A1 | |
| SCHEMBL2263988 | 0.86 | MCL1 (0.74) | MCL1GAAKMT2AMEN1ALDH1A1 | |
| SCHEMBL22803077 | 0.85 | MCL1 (0.73) | MCL1KMT2AMEN1ALDH1A1HPGD | |
| SCHEMBL29249541 | 0.84 | MCL1 (0.72) | MCL1GAAKMT2AMEN1LMNA | |
| SCHEMBL19277778 | 0.82 | MCL1 (0.69) | MCL1GAAKMT2AMEN1ALDH1A1 | |
| SCHEMBL2265490 | 0.82 | MCL1 (0.70) | MCL1GAAHPGDRAB9AL3MBTL1 | |
| SCHEMBL12389322 | 0.82 | MCL1 (0.70) | MCL1GAAKMT2AMEN1ALDH1A1 | |
| SCHEMBL2264964 | 0.82 | MCL1 (0.70) | MCL1KMT2AALDH1A1HTTHPGD | |
| SCHEMBL2268566 | 0.82 | MCL1 (0.70) | MCL1KMT2AALDH1A1HTTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115974721-B | Method for synthesizing 2-carbonyl substituted nitrile compound through 2, 2-trifluoroethyl ketone | 平顶山学院 | 2024-07-02 | — | — | CN | claimed |
| CN-115974721-A | Method for synthesizing 2-carbonyl substituted nitrile compound through 2,2,2-trifluoroethyl ketone | 平顶山学院 | 2023-04-18 | — | — | CN | claimed |
| CN-110709440-B | Polyurethane foams based on polyether carbonate polyols | 科思创德国股份有限公司 | 2022-03-18 | — | — | CN | claimed |
| EP-3630859-B1 | POLYURETHANE FOAMS BASED ON POLYETHER CARBONATE POLYOLS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2021-06-23 | — | — | EP | claimed |
| EP-3630859-A1 | POLYURETHANE FOAMS BASED ON POLYETHERCARBONATE POLYOLS | Covestro Deutschland AG (DE) | 2020-04-08 | — | — | EP | claimed |
| US-20200087438-A1 | POLYURETHANE FOAMS BASED ON POLYETHERCARBONATE POLYOLS | COVESTRO DEUTSCHLAND AG (DE) | 2020-03-19 | — | — | US | claimed |
| CN-110709440-A | Polyurethane foams based on polyether carbonate polyols | 科思创德国股份有限公司 | 2020-01-17 | — | — | CN | claimed |
| WO-2018219893-A1 | POLYURETHANE FOAMS BASED ON POLYETHERCARBONATE POLYOLS | COVESTRO DEUTSCHLAND AG (DE) | 2018-12-06 | — | — | WO | claimed |
| EP-3409704-A1 | POLYURETHANE FOAMS BASED ON POLYETHER CARBONATE POLYOLS | Covestro Deutschland AG (DE) | 2018-12-05 | — | — | EP | claimed |
| US-20260070877-A1 | FLUORINE-CONTAINING PYRIDONE COMPOUND AND METHOD FOR PRODUCING SAME | UNIMATEC CO., LTD. (JP) | 2026-03-12 | — | — | US | disclosed |
| EP-4628482-A1 | FLUORINE-CONTAINING PYRIDONE COMPOUND AND METHOD FOR PRODUCING SAME | Unimatec Co., Ltd. (JP) | 2025-10-08 | — | — | EP | disclosed |
| CN-115974721-B | Method for synthesizing 2-carbonyl substituted nitrile compound through 2, 2-trifluoroethyl ketone | 平顶山学院 | 2024-07-02 | — | — | CN | disclosed |
| CN-118271238-A | 2-Cyanoacrylamides derivatives and use thereof | 四川大学 | 2024-07-02 | — | — | CN | disclosed |
| WO-2024116528-A1 | FLUORINE-CONTAINING PYRIDONE COMPOUND AND METHOD FOR PRODUCING SAME | ユニマテック株式会社 | 2024-06-06 | — | — | WO | disclosed |
| US-4537781-A | Pharmaceutically useful malonamides | RESEARCH CORPORATION (US) | 1985-08-27 | — | — | US | disclosed |
| EP-0135189-A2 | Pharmaceutically useful malonamides | Research Corporation (US) | 1985-03-27 | — | — | EP | disclosed |
| US-4393217-A | ANXIOLYTICS, ANTIDEPRESSANTS | AMERICAN CYANAMID COMPANY (US) | 1983-07-12 | — | — | US | disclosed |
| US-4104273-A | Derivatives of 3-cyano-pyrid-2-ones | ROHM AND HAAS COMPANY (US) | 1978-08-01 | — | — | US | disclosed |
| US-4028084-A | Derivatives of 3-carboxy pyrid-2-ones | ROHM AND HAAS COMPANY (US) | 1977-06-07 | — | — | US | disclosed |
| US-3985763-A | DYESTUFFS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070877-A1 | FLUORINE-CONTAINING PYRIDONE COMPOUND AND METHOD FOR PRODUCING SAME | NR4A1, POF1B, NR0B2 | MCL1 994/4885GAA 4830/4885KMT2A 1362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.